High sensitivity
Results in accurate breast cancer diagnosis1.
Quick and efficient
Takes down 7 minutes to perform a SenoBright HD exam2.
30 CEM exams a day3.
High specificity
For low false-positives and help prevent unnecessary exams1.
Care for more patients
43% of patients wouldn’t come back for follow-up4.
Provide answers to your patients right away and help them avoid the agonizing wait that comes with an inconclusive exam. Don’t seek, see. Accelerate your ability to make a confident diagnosis.
• Helps reduce the masking effect of fibroglandular breast tissue and increases the tumour signal1.
• Contrast agent highlights areas of unusual blood flow.
• CEM is an alternative imaging method to MRI, especially when MRI availability is limited, and for patients for whom MRI is contraindicated5.
• Find lesions that cannot be seen on routine mammography6,7,8.
• Provide high specificity for low false-positives1.
• With Nira, overall Image quality was better assessed in more than 98% of the images presented by all the readers9.
• Expand to a large population of women who can access this technology for Equitable care.
• Reduce agonizing wait time for women to get to a confident diagnosis.
• Target the 43% of patients who would not come back for follow-up4.
• Filter out false positives to make room for those in true need1.
• Meets reimbursement criterion for this exam without pre-authorization.
• Can perform the imaging exam in less than 7 minutes2, on a machine and with staff women are familiar with.
Testimonial from Gaelyn Scuderi, Ackerman Cancer Center, USA.
Testimonial from Jason P. Shames, Jefferson-Honickman Breast Imaging Center, USA.
Testimonial from Zachariah D. Kuchta, Founder & CEO of Expert Breast Imaging, USA.
1. 510(k) K172404.
2. Data on file. GE HealthCare 2017.
3. Over 8 hours. Data on file, GE HealthCare 2019.
4. Andrew Mosier DO, Esha Gupta MD, Dana Ataya MD, Kavita Bhatt MD, Alice Rim MD.
March 2017. https://doi.org/10.1111/tbj.12784.
5. Phillips et al. Workflow Considerations for Incorporation of Contrast-Enhanced Spectral
Mammography Into a Breast Imaging Practice, ACR, 2018 https://www.jacr.org/article/S1546-1440(18)30205-9/fulltext
6. Compared to without contrast.
7. J. Sung et al., Radiology 2019; 00:1-8.
8. V. Sorin et al. American Journal of Roentgenology: W267-W274. 10.2214/
AJR.17.1935510(k) K172404.
9. 510(k) K211215. Reader study performed by 3 MQSA qualified radiologists on 50 clinical
images, comparing SenoBright HD with NIRA to current version.
* Superior diagnostic accuracy demonstrated in a reader study comparing the ROC AUC of GE screening protocol (V-Preview + 3D CC/MLO with 3D in STD mode) to that of 2D FFDM alone. V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P130020.
** As compared to Pristina Serena 2D biopsy. Data on file GE HealthCare 2018.